Results 31 to 40 of about 59,439 (317)
Scientific Reports, 2018 A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
A. Suraev +10 more
doaj +1 more source
, 2008 INTRODUCTION: Ghrelin and cannabinoids stimulate appetite, this effect possibly being mediated by the activation of hypothalamic AMP-activated protein kinase (AMPK), a key enzyme in appetite and metabolism regulation. The cannabinoid receptor type 1 (CB1)
Judith Harvey-White +59 more
core +1 more source
Cannabinoids for epilepsy [PDF]
Cochrane Database of Systematic Reviews, 2011 Marijuana appears to have anti-epileptic effects in animals. It is not currently known if it is effective in patients with epilepsy. Some states in the United States of America have explicitly approved its use for epilepsy.To assess the efficacy of marijuana, or one of marijuana's constituents in the treatment of people with epilepsy.We searched the ...
David, Gloss, Barbara, Vickrey
openaire +3 more sources
Journal of Dermatological Treatment, 2022 Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities. Current treatments often prove unsatisfactory, especially in sufferers of generalized hyperhidrosis.
Till Kaemmerer +4 more
openaire +3 more sources
Plant Direct, 2022 Cannabinoids are predominantly produced in the glandular trichomes on cannabis female flowers. There is little known on how cannabinoid biosynthesis is regulated during female flower development.
Peter V. Apicella +3 more
doaj +1 more source
Axially Chiral Cannabinoids: Design, Synthesis, and Cannabinoid Receptor Affinity
, 2023 The resorcinol-terpene phytocannabinoid template is a privileged scaffold for the development of diverse therapeutics target-ing the endocannabinoid system. Axially chiral cannabinols (axCBNs) are unnatural cannabinols (CBNs) that bear an addi-tional C10
Sara , Kearney +10 more
core +1 more source
Pain Research and Management, 2001 Cannabinoids have been used to treat pain for many centuries. However, only during the past several decades have rigorous scientific methods been applied to understand the mechanisms of cannabinoid action. Cannabinoid receptors were discovered in the late 1980s and have been found to mediate the effects of cannabinoids on the nervous system.
J Michael Walker +2 more
openaire +3 more sources
Pharmacogenetics of Cannabinoids [PDF]
European Journal of Drug Metabolism and Pharmacokinetics, 2017 Although the application of medical marijuana and cannabinoid drugs is controversial, it is a part of modern-day medicine. The list of diseases in which cannabinoids are promoted as a treatment is constantly expanding. Cases of significant improvement in patients with a very poor prognosis of glioma or epilepsy have already been described. However, the
Hryhorowicz, Szymon +4 more
openaire +2 more sources
Release of anandamide from blood cells [PDF]
, 2006 Background: Endogenous ligands of cannabinoid receptors ( endocannabinoids), in particular anandamide ( arachidonylethanolamide), have been recognized as being of crucial importance in a variety of physiological functions.
Storr, Martin +5 more
core +1 more source
Canadian Journal of Gastroenterology and Hepatology, 2009 Cannabinoid hyperemesis syndrome is characterized by chronic, heavy use of cannabis, recurrent episodes of severe nausea and intractable vomiting, and abdominal pain. Temporary relief of symptoms is achieved by taking a hot bath or shower, and resolution of the problem when cannabis use is stopped.
openaire +3 more sources